EU, FDA to share inspections data; EU signs off on Optimer, Astellas, diarrhea … – FiercePharma


EU, FDA to share inspections data; EU signs off on Optimer, Astellas, diarrhea
FiercePharma
Story > Optimer Pharmaceuticals ($ OPTR) and Astellas Pharma have gained marketing approval in Europe for DIFICLIR (fidaxomicin) tablets to treat adults with Clostridium difficile-associated diarrhea. Optimer release > Takeda will begin Canadian
The European Commission Grants Marketing Authorization for DIFICLIR PR Newswire (press release)
Optimer Wins EU Approval for New AntibioticXconomy

all 21 news articles »

diarrhea – Google News